Etubics has received an approximately $1.5 million contract from the Small Business Innovation Research Development Center of the National Cancer Institute to manufacture its breast cancer immunotherapeutic, ETBX-021.
http://www.news-medical.net/news/20130927/SBIR-Awards-Etubics-2415M-To-Manufacture-Breast-Cancer-Immunotherapy.aspx
http://www.news-medical.net/news/20130927/SBIR-Awards-Etubics-2415M-To-Manufacture-Breast-Cancer-Immunotherapy.aspx
No comments:
Post a Comment